Adenoid cystic carcinoma
Adenoid cystic carcinoma (ACC) is a rare form of cancer that primarily affects the salivary glands but can also occur in other parts of the body. It is characterized by slow growth, but it is also known for its potential to spread and recur.
Epidemiology[edit | edit source]
ACC accounts for approximately 1% of all head and neck cancers, and about 10% of all salivary gland tumors. It can occur at any age but is most commonly diagnosed in individuals between the ages of 40 and 60. There is a slight female predominance.
Pathophysiology[edit | edit source]
ACC arises from the secretory cells of the salivary glands. It is characterized by a distinctive pattern of growth, with tumor cells forming structures that resemble the normal architecture of the glands. The tumor cells produce excessive amounts of mucin, a sticky substance that can cause the tumor to adhere to surrounding tissues and make it difficult to remove surgically.
Clinical Presentation[edit | edit source]
The most common symptoms of ACC are a slowly enlarging mass, pain, and nerve involvement leading to facial weakness or numbness. Depending on the location of the tumor, other symptoms may include difficulty swallowing, changes in voice, or breathing difficulties.
Diagnosis[edit | edit source]
The diagnosis of ACC is typically made by biopsy of the tumor. Imaging studies such as CT scan or MRI may be used to determine the extent of the disease.
Treatment[edit | edit source]
Treatment for ACC typically involves surgery to remove the tumor, often followed by radiation therapy. In cases where the tumor cannot be completely removed, radiation therapy may be used as the primary treatment. Chemotherapy is generally reserved for cases where the disease has spread to other parts of the body.
Prognosis[edit | edit source]
The prognosis for ACC is variable, depending on factors such as the size and location of the tumor, the extent of disease at the time of diagnosis, and the patient's overall health. Despite its slow growth, ACC is known for its potential to spread and recur, and long-term follow-up is typically recommended.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD